|1|Obesity, Health-Care Utilization, and Health-Related Quality of Life After Fracture in Postmenopausal Women: Global Longitudinal Study of Osteoporosis in Women (GLOW). (24077896)
Compston J.E.... Gehlbach S.H.
|2|The relationship between fibroblast growth factor 23 and osteoporosis in postmenopausal women. (24101107)
Celik E.... KuAsukyalcin V.
Diab D.L.... Watts N.B.
|4|Discontinuation and reinitiation patterns of osteoporosis treatment among commercially insured postmenopausal women. (24235846)
Balasubramanian A.... Critchlow C.W.
|5|Osteoporosis in postmenopausal women: considerations in prevention and treatment: (women's health series). (24305532)
Sanders S.... Geraci S.A.
|6|Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24A weeks in postmenopausal women with osteoporosis. (24108429)
Sugimoto T.... Shiraki M.
|7|Consumption of vitamin D-and calcium-fortified soft white cheese lowers the biochemical marker of bone resorption TRAP 5b in postmenopausal women at moderate risk of osteoporosis fracture. (22357739)
Bonjour J.P.... Souberbielle J.C.
|8|Does autonomic dysfunction exist in postmenopausal osteoporosis? (22019965)
Tosun A.... EbinAs H.
|9|The association of IL-1beta, IL-2, and IL-6 gene polymorphisms with bone mineral density and osteoporosis in postmenopausal women. (20060205)
Czerny B.... Pawlik A.
|10|Search for hidden secondary causes in postmenopausal women with osteoporosis. (19593233)
CerdA! Gabaroi D.... GuaA+abens N.
|11|Relationships between endothelial nitric oxide synthase gene polymorphisms and osteoporosis in postmenopausal women. (19650200)
Liu S.Z.... Lu S.M.
|12|Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective. (19049341)
Kuchuk N.O.... Lips P.
|13|Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis. (19857095)
|14|Effect of risedronate on biochemical marker of bone resorption in postmenopausal women with osteoporosis or osteopenia. (18382907)
Dane C.... Erginbas M.
|15|Head-to-head comparison of risedronate vs. teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomised trial. (18422590)
Anastasilakis A.D.... Avramidis A.
|16|Effects of warm needle moxibustion on bone mass density and biochemical indexes of bone metabolism in patients of postmenopausal osteoporosis]. (19127918)
Zhao L.H.... Ye F.W.
|17|Treatment and prevention practices in postmenopausal women after bone mineral density screening at a community-based osteoporosis project. (16912337)
Rohr C.I.... Sarkar A.
|18|Effectiveness of intranasal salmon calcitonin treatment in postmenopausal osteoporosis]. (15908722)
|19|Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis. (15653003)
Warming L.... Christiansen C.
|20|Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis. (15838627)
Iwamoto J.... Uzawa M.
|21|A specific haplotype in the 3' end of estrogen-receptor alpha gene is associated with low bone mineral density in premenopausal women and increased risk of postmenopausal osteoporosis. (15647972)
Ongphiphadhanakul B.... Rajatanavin R.
|22|Review of treatment modalities for postmenopausal osteoporosis. (16295815)
Hamdy R.C.... Watts N.B.
|23|Comparison of cyclic and continuous calcitonin regimens in the treatment of postmenopausal osteoporosis. (15660234)
TekeoA9lu I.... Ediz L.
|24|Genetically defined adult-type hypolactasia and self-reported lactose intolerance as risk factors of osteoporosis in Finnish postmenopausal women. (16015262)
Enattah N.... JAorvelAo I.
|25|Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Prevention Study. (15465502)
Ishida Y.... Kawai S.
|26|A comprehensive review of treatments for postmenopausal osteoporosis. (12577179)
HAouselmann H.J.... Rizzoli R.
|27|Circulating osteoprotegerin and leptin levels in postmenopausal women with and without osteoporosis. (15526523)
Grigorie D.... Popa O.
|28|The effects of alendronate and calcitonin on cytokines in postmenopausal osteoporosis: a 6-month randomized and controlled study. (12619182)
GA1r A.... SaraAs A.J.
|29|Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: a cross-sectional study. (12629078)
Ueland T.... Bollerslev J.
|30|Treatment with vitamin D3 and/or vitamin K2 for postmenopausal osteoporosis. (14529146)
Iwamoto J.... Ichimura S.
|31|Osteoprotegerin/RANKL/RANK system and postmenopausal osteoporosis. The possible therapeutic aspects]. (12916277)
Kapczuk K.... Friebe Z.
|32|Inverse relation between osteoporosis and spondylosis in postmenopausal women as evaluated by bone mineral density and semiquantitative scoring of spinal degeneration. (12616163)
Miyakoshi N.... Minato T.
|33|Two polymorphisms in the vitamin D receptor gene--association with bone mass and 5-year change in bone mass with or without hormone-replacement therapy in postmenopausal women: the Danish Osteoporosis Prevention Study. (12162507)
Tofteng C.L.... Brot C.
|34|The role of trace minerals in the pathogenesis of postmenopausal osteoporosis and a new effect of calcitonin. (11810415)
GA1r A.... DA1z M.Z.
|35|Relation of BsmI vitamin D receptor gene polymorphism to bone mineral density and occurrence of osteoporosis in postmenopausal Chinese women in Taiwan. (11846330)
Chen H.Y.... Li C.W.
|36|Effects of the combined use of calcitonin and 1 alpha-hydroxycholecalciferol on vertebral bone loss and bone turnover in women with postmenopausal osteopenia and osteoporosis: a prospective study of long-term and continuous administration with low dose calcitonin. (11731184)
Ushiroyama T.... Ueki M.
|37|Comparison of alendronate, calcitonin and calcium treatments in postmenopausal osteoporosis. (11695068)
Dursun N.... YalAsin S.
|38|A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. (10996576)
Chesnut C.H.... Baylink D.
|39|Osteoblast numbers after calcitonin therapy: a retrospective study of paired biopsies obtained during long-term calcitonin therapy in postmenopausal osteoporosis. (10602841)
Gruber H.E.... Chesnut Ill C.H.
|40|Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women. (10843152)
Downs R.W.... Melton M.E.
|41|Postmenopausal osteoporosis in women]. (10389480)
Reginster J.Y.... Vanhaelst L.
|42|Colles' fracture of the wrist as an indicator of underlying osteoporosis in postmenopausal women: a prospective study of bone mineral density and bone turnover rate. (9692078)
Earnshaw S.A.... Hosking D.J.
|43|Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. (9783545)
Yamada Y.... Ikeda K.
|44|New biochemical markers of bone resorption in the study of postmenopausal osteoporosis. (9385464)
de la Piedra C.... Sosa HenrA-quez M.
|45|Parathyroid hormone and related peptides for the treatment of postmenopausal osteoporosis. (15989633)
|46|Cyclical pamidronate infusions in postmenopausal osteoporosis. (8887311)
Peretz A.... Bergmann P.
|47|Human marrow stromal osteoblast-like cells do not show reduced responsiveness to in vitro stimulation with growth hormone in patients with postmenopausal osteoporosis. (8118745)
Kassem M.... Eriksen E.F.
|48|Rectal salmon calcitonin for the treatment of postmenopausal osteoporosis. (1422962)
Overgaard K.... Christiansen C.
|49|Postmenopausal osteoporosis--definition, pathogenesis, prevention and therapy]. (1792568)
|50|Usefulness of bone remodelling biochemical markers in the diagnosis and follow-up of Paget's bone disease, primary hyperparathyroidism, tumor hypercalcemia, and postmenopausal osteoporosis. II. Bone resorption markers]. (2104101)
de la Piedra Gordo C.... Torres JimAcnez R.